Kestra Medical Technologies, Ltd.

KMTSCIK 0001877184 · Every Form 4 filed by insiders at this issuer. See financials →

Annual report (10-K)

Latest 10-K filed Jul 17, 2025. Sentiment + YoY language diff vs prior year. Read sections →

Signal:No prior 10-KFull-doc fallback

Full filing:tone -0.0152

Sentiment via Loughran-McDonald lexicon · YoY diff via Jaccard similarity + paragraph set difference.

Recent 8-K announcements

Per-item disclosure feed. Item 2.02 is the earnings release.

Mar 17, 2026no items parsed Dec 11, 2025no items parsed Dec 4, 2025no items parsed Dec 1, 20252.02 · Results9.01 · Financial Statements and Exhibits Nov 10, 2025no items parsed

YoY shift: Unscored

Year-over-year tone shift - average net-tone change across Risk Factors and MD&A vs the prior 10-K.

Why YoY instead of absolute: the LM lexicon has ~6.6× more negative words than positive (legal/risk-disclosure language is heavy on hedging), so every 10-K reads bearish on raw tone. Year-over-year change strips that bias and surfaces the actual shift in management's framing.

Per-snippet highlights

Sentence-level sentiment highlighting with category and subcategory filters is coming once the snippet-scoring pipeline lands. For now, dig into the actual section text on the Sections tab.

Top insiders

Most active reporters at Kestra Medical Technologies, Ltd.

Name	Roles	Filings
Schwartz Jeffrey Lawrence	Director10% Owner	1

Showing 11-11 of 11

Per pagePrevPage 3 of 3

Top performers

Insiders ranked by realized 90-day signed return on their open-market trades at Kestra Medical Technologies, Ltd.. Minimum 3 scored trades. Returns are signed - a sale followed by a rally counts against the insider.

#	Insider	Trades	Win rate	Avg	Median	Best	Worst
1	Webster Brian Daniel	5	100%	+23.5%	+24.9%	+30.6%	+12.1%

All filings

27 Form 4 / 4-A filings, newest first

Filed	Insider	Top transaction	Shares	Price	Value
Jun 4, 2026	Webster Brian Daniel See Remarks · Director	AGrant	75,681	$0.00	$0

Filed		Top transaction	Shares	Price	Value